Výsledky vyhledávání - Jörg Trojan

Upřesnit hledání
  1. 1
    Diagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and Developments

    Diagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and Developments Autor Jörg Trojan, Stephan Zangos, Andreas A. Schnitzbauer

    Vydáno 2016
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Perceptual drifts of real and artificial limbs in the rubber hand illusion

    Perceptual drifts of real and artificial limbs in the rubber hand illusion Autor Xaver Fuchs, Martin Riemer, Martin Diers, Herta Flor, Jörg Trojan

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Systemic Therapy of Advanced Hepatocellular Carcinoma

    Systemic Therapy of Advanced Hepatocellular Carcinoma Autor Peter R. Galle, Jean‐François Dufour, Markus Peck‐Radosavljevic, Jörg Trojan, Arndt Vogel

    Vydáno 2020
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer

    Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer Autor Jörg Trojan, Sebastian Stintzing, Oliver Haase, Christine Koch, Paul Ziegler, Melanie Demes, Ivan Jelas

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study

    Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study Autor Fabian Finkelmeier, Bernd Kronenberger, Verena Köberle, Jörg Bojunga, Stefan Zeuzem, Jörg Trojan, Albrecht Piiper, Oliver Waidmann

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success

    Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success Autor Thomas J. Vogl, N Naguib, Nour‐Eldin A. Nour‐Eldin, Wolf O. Bechstein, Stefan Zeuzem, Jörg Trojan, Tatjana Gruber‐Rouh

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    An augmented reality home-training system based on the mirror training and imagery approach

    An augmented reality home-training system based on the mirror training and imagery approach Autor Jörg Trojan, Martin Diers, Xaver Fuchs, Felix Bach, Robin Bekrater‐Bodmann, Jens Foell, Sandra Kamping, Mariela Rance, H. Maaß, Herta Flor

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Chemosaturation with Percutaneous Hepatic Perfusions of Melphalan for Hepatic Metastases: Experience from Two European Centers

    Chemosaturation with Percutaneous Hepatic Perfusions of Melphalan for Hepatic Metastases: Experience from Two European Centers Autor Thomas J. Vogl, S Zangos, J Scholtz, Felix C. F. Schmitt, S. Christine Paetzold, Jörg Trojan, Franco Orsi, Gösta Lotz, Pier Francesco Ferrucci

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

    Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study Autor Frank Kullmann, S. Hollerbach, Matthias Dollinger, Jan Harder, Martin Fuchs, Helmut Messmann, Jörg Trojan, E Gäbele, Axel Hinke, Cathérine Hollerbach, Esther Endlicher

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers

    Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers Autor Vera Himmelsbach, Matthias Pinter, Bernhard Scheiner, Marino Venerito, Friedrich Sinner, Carolin Zimpel, Jens U. Marquardt, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    The Importance of Synchrony and Temporal Order of Visual and Tactile Input for Illusory Limb Ownership Experiences – An fMRI Study Applying Virtual Reality

    The Importance of Synchrony and Temporal Order of Visual and Tactile Input for Illusory Limb Ownership Experiences – An fMRI Study Applying Virtual Reality Autor Robin Bekrater‐Bodmann, Jens Foell, Martin Diers, Sandra Kamping, Mariela Rance, Pinar Kirsch, Jörg Trojan, Xaver Fuchs, Felix Bach, Hüseyin Çakmak, H. Maaß, Herta Flor

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

    Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial Autor Oliver Nehls, Helmut Oettle, J. T. Hartmann, R. D. Hofheinz, H G Hass, Marius Horger, Ursula Koppenhöfer, Andreas Hochhaus, Jens Stieler, Jörg Trojan, Michael Gregor, Bodo Klump

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth

    Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth Autor Uta Rabenhorst, Rasa Beinoravičiūtė-Kellner, M.-L. Brezniceanu, Stefan Joos, Frauke Devens, Peter Lichter, Ralf J. Rieker, Jörg Trojan, Hye Jung Chung, David Levens, Martin Zörnig

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Transarterial chemoembolization of unresectable systemic chemotherapy‐refractory liver metastases from colorectal cancer: Long‐term results over a 10‐year period

    Transarterial chemoembolization of unresectable systemic chemotherapy‐refractory liver metastases from colorectal cancer: Long‐term results over a 10‐year period Autor Tatjana Gruber‐Rouh, N Naguib, Katrin Eichler, Hanns Ackermann, Stephan Zangos, Jörg Trojan, Martin Beeres, Marc Harth, Boris Schulz, Nour‐Eldin Nour‐Eldin A., Thomas J. Vogl

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions

    Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions Autor Jessica C. Hassel, Lucie Heinzerling, Jens Aberle, Oliver Bähr, Thomas Eigentler, Marc‐Oliver Grimm, Victor Grünwald, Jan Leipe, Niels Reinmuth, Julia K. Tietze, Jörg Trojan, Lisa Zimmer, Ralf Gutzmer

    Vydáno 2017
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

    Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial Autor Stefan Boeck, K. Weigang-Köhler, Martin Fuchs, E. Kettner, D. Quietzsch, Jörg Trojan, Oliver Stötzer, Stefan Zeuzem, Florian Lordick, C-H Köhne, H. Kröning, Tilmann Steinmetz, H. Depenbrock, Volker Heinemann

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

    Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer Autor Maren Knödler, Justus Körfer, Volker Kunzmann, Jörg Trojan, S Daum, Michael Schenk, Frank Kullmann, Sebastian Schroll, Dirk Behringer, Michael Stahl, Salah‐Eddin Al‐Batran, Ulrich Hacker, Stefan Ibach, Horst Lindhofer, Florian Lordick

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma

    Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma Autor Verena Bihrer, Oliver Waidmann, Mireen Friedrich‐Rust, Nicole Forestier, S. Süsser, Jörg Haupenthal, Martin Welker, Yongyong Shi, Jan Peveling‐Oberhag, Andreas Polta, Michael Wagner, Heinfried H. Radeke, Christoph Sarrazin, Jörg Trojan, Stefan Zeuzem, Bernd Kronenberger, Albrecht Piiper

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

    Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer Autor Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla, Denis Pezet, G. Deplanque, Martin Fuchs, Jörg Trojan, Helmut Oettle, Mark Kozloff, Ann Cleverly, Claire Smith, Shawn T. Estrem, Ivelina Gueorguieva, Michael Lahn, Al Blunt, Karim A. Benhadji, Josep Tabernero

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies

    Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies Autor Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, Thomas Berg, Arndt Vogel, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Anja Eiblmaier, Hanns‐Georg Klein, Johannes Kolja Hegel, Kairat Madin, Konstantin Kroeniger, Ashish Sharma, Henry Lik‐Yuen Chan

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: